Log in Register

Anti-CR2 [BU32]


Catalogue Number 151431
Applications FACS IHC IF
Antigen/Gene or Protein Targets Complement component (3d/Epstein Barr virus) receptor 2 (CR2, CD21)
Synonyms Complement Component 3d Receptor 2; Epstein-Barr Virus Receptor 2; Complement C3d Receptor; EBV Receptor; C3DR; CD21 Antigen; CVID7; SLEB9; CD21; Cr2; CR
Reactivity Human
Relevance CR2 is expressed strongly on mature B cells, follicular dentritic cells and weakly on immature thymocytes and T lymphocytes. In B-cell ontogeny, CR2 appears after the pre-B-stage, is maintained during peripheral B-cell development and is lost upon terminal differentiation into plasma cells. CR2 expression is also gradually lost after stimulation of B cells in vitro. CR2 functions as a receptor for C3d, C3dg and iC3b Complement components and for EBV and for IFN alpha. CR2 binds to CD23 and associates with CD19, CD81 and Leu13 to form a large signal-transduction complex involved in B-cell activation. By inducing release of proinflammatory cytokines and upregulating expression of molecules involved in antigen presentation, CR2 modulates critical monocyte functions that may be relevant to allergic and inflammatory disorders.
Host Mouse
Immunogen Myeloma cell line Rob
Subclass IgG1
Myeloma Used NS0
Recommended Growing Conditions RPMI 1640 + 10% FCS
Strain Balb/c
Research Area Cell Signaling & Signal Transduction, Immunology

References: 7 entries

Knapp, W. et al. eds. 1989. Leucocyte Typing IV Oxford University Press. ISBN-13: 978-0192618672

Leucocyte Typing III 1987. ISBN-13: 978-0192615527

Leucocyte Typing V 1995. ISBN-13: 978-0192623768

Leucocyte Typing VI 1998. Garland Publishing NY. ISBN-13: 978-0815327455

Ling, NR., Brown, B., Immunobiology (1992) 185(2-4) pp403-14

Masilamani et al. 2004. Rheumatology (Oxford). 43(2):186-90. PMID: 12867574.

Aubry et al. 1992. Nature. 358(6386):505-7. PMID: 1386409.

Add a reference

This reagent does not have any reviews at the moment.